ITMCTR1900002282
Recruiting
Phase 4
A study for Efficacy and Safety of Metronomic Administration of Detoxification Chinese Herbs combined with Thalidomide in the Treatment of Elderly or Refractory Relapsed Lymphoma
Shanghai Municiple hospital of Traditional Chinese Medicine0 sitesTBD
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Shanghai Municiple hospital of Traditional Chinese Medicine
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Meet the pathological diagnostic criteria of lymphoma (pathological types are not limited);
- •2\. Meet the diagnostic criteria for elderly or refractory or relapsed;
- •3\. Patients assessed as inappropriate or intolerable or unwilling to receive combination chemotherapy and targeted therapy;
- •4\. ECOG\=3;
- •5\. Survival is expected to be greater than 3 months;
- •6\. Having signed the informed consent.
Exclusion Criteria
- •1\. Aged\<18 years;
- •2\. Pregnant or lactating women;
- •3\. History of thrombosis nearly 2 years;
- •4\. Allergic or allergic to various drugs;
- •5\. Severe liver and kidney dysfunction;
- •6\. With severe infection or difficult to control;
- •7\. Taking other traditional Chinese medicine or taking other clinical trials nearly 2 weeks;
- •8\. The investigators concluded that patients should not take any other part of the study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
The study of small dose chemotherapy after surgery not fit for radiotherapy in recurrent head and neck cancers patients.Health Condition 1: null- recurrent head and neck cancers patients post R0 salvage surgical resection who are ineligible for re-irradiation.CTRI/2016/04/006872Tata Memorial Hospital400
Completed
Not Applicable
Investigation of the effectiveness of metronome pacing on freezing of gaitParkinson's diseaseJPRN-UMIN000027989Hiroshima University6
Recruiting
Not Applicable
Multi-parametric profiling of cancer patient samples and metronomic chemotherapy for forensic and treatment outcomes.Health Condition 1: C509- Malignant neoplasm of breast of unspecified siteCTRI/2024/07/070026A
Not yet recruiting
Not Applicable
Comparative study of efficacy and safety of Administering 4mg once daily and 2mg twice daily of silodosin in patients with benign prostatic hyperplasiabenign prostatic hyperplasiaJPRN-UMIN000002188JR Tokyo General Hospital100
Not yet recruiting
Phase 4
A study to compare the effect of of Metformin with Teneligliptin versus Metformin with Glimepiride in patients of Type 2 Diabetes MellitusCTRI/2020/04/024425AIIMS Patna